The global diabetes treatment devices market is witnessing significant growth, driven by the rising prevalence of diabetes and advancements in medical technology. As the demand for effective diabetes management solutions increases, the market is poised for substantial expansion in the coming years.

The global diabetes treatment devices market size was valued at USD 10.83 billion in 2018 and is projected to reach USD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period. North America dominated the global market, holding a share of 40.44% in 2018.

Top Companies in the Diabetes Treatment Devices Market

Leading players in the diabetes treatment devices industry include:

• F. Hoffmann-La Roche Ltd
• Tandem Diabetes Care, Inc.
• B. Braun Melsungen AG
• Medtronic
• BD
• Novo Nordisk A/S
• Abbott
• Sanofi
• Other players

Get More Information: https://www.fortunebusinessinsights.com/industry-reports/diabetes-treatment-devices-market-100777

Key Industry Developments

• March 2021: F. Hoffmann-La Roche Ltd announced the launch of a new Accu-Check Instant system, a blood glucose monitoring system that supports Roche’s integrated personalized diabetes management approach.
• April 2021: BIOCORP and Roche Diabetes Care, France launched Mallya, a smart insulin injection pen in France, leveraging Roche’s distribution network in pharmacies.